Anheuser-Busch Inbev SA
BUD · NYSE
About BUD
- Employees
- 136,805
- Headquarters
- LEUVEN (LOUVAIN), Vlaams-Brabant
- Listed
- Oct 11, 2016
- Sector
- Consumer Staples
- Industry
- Beverages
- Website
- ab-inbev.com
BUD key statistics
- Market cap
- 150.41B
- Price-earnings ratio
- 0.00
- Dividend yield
- 2.43%
- Average volume
- 2.06M
- Volume
- 2.45M
- Open price
- $85.34
- High today
- $85.51
- Low today
- $84.05
- 52 Week high
- $86.60
- 52 Week low
- $59.64
Anheuser-Busch Inbev SA (BUD) at a glance
Anheuser-Busch Inbev SA (BUD) last traded at $84.26, with a market cap of 150.41B, a price-to-earnings ratio of 0.00 and a dividend yield of 2.43%.
Today the stock has traded between $84.05 and $85.51. The current price is 0.2% above the day's low and 1.5% below its high.
Volume so far is 2.45M shares, in line with the average of 2.06M shares a day.
Over the past year Anheuser-Busch Inbev SA has ranged from $59.64 to $86.60, and now sits 91% of the way up that range.
Anheuser-Busch Inbev SA met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $1.21 per share against an estimate of $1.13.
The average analyst price target is $95.29, 13.1% above the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy71.4%
- Hold28.6%
- Sell0.0%
- Low
- $68.42
- Now
- $84.26
- High
- $190.96
BUD earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 7.4% on average.
- Q3 FY24: reported $0.98 per share against an estimate of $0.9266
- Q4 FY24: reported $0.88 per share against an estimate of $0.7317
- Q1 FY25: reported $0.81 per share against an estimate of $0.7489
- Q2 FY25: reported $0.98 per share against an estimate of $0.9702
- Q3 FY25: reported $0.99 per share against an estimate of $0.9679
- Q4 FY25: reported $0.95 per share against an estimate of $0.8956
- Q1 FY26: reported $0.97 per share against an estimate of $0.8969
- Q2 FY26: reported $1.21 per share against an estimate of $1.13
BUD news
- Press releasePRNewswire
- Press releasePRNewswire
Anheuser-Busch Invests $21 Million in Los Angeles, CA Facilities, Expands Local Manufacturing Skills Training
- Press releaseBusiness Wire
Netflix and Stella Artois Bring the Perfect Serve to The Gentlemen Season 2
- Press releasePRNewswire
Anheuser-Busch Invests $13 Million in Baldwinsville, NY Brewery, Expands Local Manufacturing Skills Training
- Press releasePRNewswire
Tunnel to Towers Foundation & Anheuser-Busch Expand Longstanding Partnership in Honor of the 25th Anniversary of 9/11
- Press releasePRNewswire
NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
- Press releaseBusiness Wire
‘Cheers to Beer’ Celebrates the Drink at the Heart of Life’s Meaningful Moments
Reported Earlier, 'Beer Dynasty Families Sell €731 Million Stake in AB InBev' - Bloomberg
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.